These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3346485)

  • 1. Nasal mucosal blood flow after intranasal allergen challenge.
    Holmberg K; Bake B; Pipkorn U
    J Allergy Clin Immunol; 1988 Mar; 81(3):541-7. PubMed ID: 3346485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reflex activation in allergen-induced nasal mucosal vascular reactions.
    Holmberg K; Bake B; Pipkorn U
    Acta Otolaryngol; 1989; 108(1-2):130-5. PubMed ID: 2763831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anterior rhinomanometry in nasal allergen challenges.
    Ferreira MB; Carlos AG
    Allerg Immunol (Paris); 1998 Nov; 30(9):295-7. PubMed ID: 9887989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of ramatroban (BAY u 3405), a thromboxane A2 receptor antagonist, on nasal cavity volume and minimum cross-sectional area and nasal mucosal hemodynamics after nasal mucosal allergen challenge in patients with perennial allergic rhinitis.
    Terada N; Yamakoshi T; Hasegawa M; Tanikawa H; Maesako K; Ishikawa K; Konno A
    Acta Otolaryngol Suppl; 1998; 537():32-7. PubMed ID: 9870646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of levocetirizine on nasal provocation testing with adenosine monophosphate compared with allergen challenge in allergic rhinitis.
    Vaidyanathan S; Nair A; Barnes ML; Meldrum K; Lipworth BJ
    Clin Exp Allergy; 2009 Mar; 39(3):409-16. PubMed ID: 19187327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages.
    Gosset P; Tillie-Leblond I; Malaquin F; Durieu J; Wallaert B; Tonnel AB
    Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late-phase allergic reaction in nasal provocation with fungal allergens.
    Niedoszytko M; Chełmińska M; Chełmiński K; Knopińska-Posłuszny W; Gruchała-Niedoszytko M; Jassem E
    Allergy Asthma Proc; 2008; 29(1):35-9. PubMed ID: 18302836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular effects of topically applied bradykinin on the human nasal mucosa.
    Holmberg K; Bake B; Pipkorn U
    Eur J Pharmacol; 1990 Jan; 175(1):35-41. PubMed ID: 2323344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of terfenadine on unilateral nasal challenge with allergen.
    Wagenmann M; Baroody FM; Kagey-Sobotka A; Lichtenstein LM; Naclerio RM
    J Allergy Clin Immunol; 1994 Mar; 93(3):594-605. PubMed ID: 7512101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of the blood flow of the nasal mucosa by the hydrogen clearance method.
    Tanimoto H; Okuda M; Yagi T; Ohtsuka H
    Rhinology; 1983 Mar; 21(1):59-65. PubMed ID: 6190210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trial design, nasal allergen challenge models, and considerations of relevance to pediatrics, nasal polyposis, and different classes of medication.
    Akerlund A; Andersson M; Leflein J; Lildholdt T; Mygind N
    J Allergy Clin Immunol; 2005 Mar; 115(3 Suppl 1):S460-82. PubMed ID: 15746883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal conditioning in perennial allergic rhinitis after nasal allergen challenge.
    Rozsasi A; Leiacker R; Keck T
    Clin Exp Allergy; 2004 Jul; 34(7):1099-104. PubMed ID: 15248856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression by ingested eicosapentaenoic acid of the increases in nasal mucosal blood flow and eosinophilia of ryegrass-allergic reactions.
    Rangi SP; Serwonska MH; Lenahan GA; Pickett WC; Blake VA; Sample S; Goetzl EJ
    J Allergy Clin Immunol; 1990 Feb; 85(2):484-9. PubMed ID: 2406326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of topical nasal anaesthesia on allergen-induced symptoms, obstruction and blood flow.
    Holmberg K; Bake B; Pipkorn U
    Clin Exp Allergy; 1989 Jul; 19(4):443-7. PubMed ID: 2667704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of vascular reflex in nasal mucosal swelling in nasal allergy.
    Numata T; Konno A; Terada N; Hanazawa T; Nagata H; Tanikawa H
    Laryngoscope; 2000 Feb; 110(2 Pt 1):297-302. PubMed ID: 10680933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy and pharmacokinetic profiles of intranasal and oral cetirizine in a repeated allergen challenge model of allergic rhinitis.
    Korsgren M; Andersson M; Borgå O; Larsson L; Aldén-Raboisson M; Malmqvist U; Greiff L
    Ann Allergy Asthma Immunol; 2007 Apr; 98(4):316-21. PubMed ID: 17458426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unilaterality of obstruction after acute nasal allergen provocation. Relation of allergen dose, nasal reactivity and the nasal cycle.
    Brooks CD; Karl KJ; Francom SF
    Clin Exp Allergy; 1991 Sep; 21(5):583-7. PubMed ID: 1742650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in the nasal mucosal microvascular with allergic rhinitis].
    Chen S
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1992; 27(1):39-40, 62. PubMed ID: 1591041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 17 and RANTES levels in induced sputum of patients with allergic rhinitis after a single nasal allergen challenge.
    Semik-Orzech A; Barczyk A; Wiaderkiewicz R; Pierzchala W
    Ann Allergy Asthma Immunol; 2009 Nov; 103(5):418-24. PubMed ID: 19927541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The time course of the bilateral release of cytokines and mediators after unilateral nasal allergen challenge.
    Wagenmann M; Schumacher L; Bachert C
    Allergy; 2005 Sep; 60(9):1132-8. PubMed ID: 16076297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.